Clinical Trials Directory

Trials / Completed

CompletedNCT05634083

Does Indoxyl Sulfate Have a Role in Uremic Pruritus?

Does Indoxyl Sulfate Have a Role in Uremic Pruritus? A Laboratory and Interventional Study.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
45 (actual)
Sponsor
Benha University · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

Itching is a widespread and disturbing complain from patients with chronic kidney disease (CKD); epidemiologic data have suggested that approximately 40% of patients with end-stage renal disease experience moderate to severe itching. The pathogenesis of renal pruritus is multifactorial. Triggering factors may include uremia-related abnormalities, accumulation of uremic toxins, systemic inflammation and cutaneous xerosis. Indoxyl sulfate (IS) is a protein-bound uremic toxin resulting from the metabolism of dietary tryptophan accumulating in patients with end-stage renal disease.

Detailed description

Patients with end-stage renal disease undergoing hemodialysis complaining of itching not related to other cause than renal failure will take activated charcoal with foods and serum level of indoxyl sulphate will be studied

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTUremic pateints with itchingActivated charcoal

Timeline

Start date
2022-11-25
Primary completion
2022-12-31
Completion
2023-01-22
First posted
2022-12-01
Last updated
2023-02-08

Locations

2 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05634083. Inclusion in this directory is not an endorsement.